All In MedTech

FDA Clearance Tracker · P080012-S031

PROMETRA PROGRAMMABLE PUMP SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 28, 2015 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 28, 2015

Approved

Time to decision

69 days

Received Oct 20, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P080012-S031
Device name
PROMETRA PROGRAMMABLE PUMP SYSTEM
Applicant location
Hackettstown, NJ
Received
Oct 20, 2015
Decided
Dec 28, 2015
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P080012

Device type

Device class
Class III

Every decision under product code LKK

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE FOLLOWING CHANGES TO THE POST-APPROVAL STUDY FOR THE DEVICE: A REVISION TO ALLOW FOR THE USE OF THE APPROVED PATIENT THERAPY CONTROLLER OR PTC IN THE POST-APPROVAL CLINICAL STUDY FOR THE PROMETRA IMPLANTABLE PROGRAMMABLE PUMP SYSTEM.

Source documents

Other decisions for Infusyn Therapeutics, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.